Swiss vote on multinational tax perks in February referendum
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Zimmer Biomet (ZBH) PT Raised to $132 at Oppenheimer Following 4Q Report
February 1, 2017 10:51 AM ESTOppenheimer raised its price target on Zimmer Biomet (NYSE: ZBH) to $132.00 (from $126.00) while maintaining a Outperform rating.
Analyst Steven Lichtman commented, "4Q16 sales of $2.013B (+3.0% organic, ex-stocking/FX, day-adjusted) were in line with ZBH's above consensus pre-announcement earlier in January; recall Americas... More
